
Patrick B Donnelly
Stock Analyst at Citi
(4.32)
# 1,398
Out of 5,133 analysts
581
Total ratings
54.1%
Success rate
6.6%
Average return
Main Sectors:
Stocks Rated by Patrick B Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAI Caris Life Sciences | Reiterated: Buy | $28 → $36 | $23.04 | +56.25% | 6 | Nov 6, 2026 | |
| TXG 10x Genomics | Reiterated: Hold | $45 → $60 | $58.19 | +3.11% | 28 | Nov 6, 2026 | |
| BRKR Bruker | Reiterated: Hold | $53 → $64 | $61.59 | +3.91% | 32 | Nov 5, 2026 | |
| MDLN Medline | Reiterated: Buy | $55 → $47 | $39.47 | +19.08% | 5 | Nov 5, 2026 | |
| ILMN Illumina | Reiterated: Sell | $113 → $210 | $207.01 | +1.44% | 45 | Nov 2, 2026 | |
| TMO Thermo Fisher Scientific | Reiterated: Buy | $685 → $800 | $700.22 | +14.25% | 32 | Oct 23, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $185 → $190 | $173.96 | +9.22% | 38 | Aug 27, 2026 | |
| FTRE Fortrea Holdings | Reiterated: Buy | $22 | $20.20 | +8.91% | 14 | Jul 31, 2026 | |
| DHR Danaher | Reiterated: Buy | $230 | $233.02 | -1.30% | 31 | Jul 22, 2026 | |
| AVTR Avantor | Reiterated: Hold | $9 → $11 | $15.54 | -29.21% | 24 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $265 | $337.97 | -21.59% | 24 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 → $215 | $151.70 | +41.73% | 23 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,550 | $1,738.91 | -10.86% | 19 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $18 | $10.74 | +67.60% | 17 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $70 → $73 | $72.80 | +0.27% | 23 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $120 → $140 | $194.65 | -28.08% | 19 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $16.61 | +38.47% | 13 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $38 | $49.89 | -23.83% | 19 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $375 → $400 | $416.42 | -3.94% | 7 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $375 → $300 | $366.36 | -18.11% | 27 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $200 | $265.12 | -24.56% | 22 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 | $319.09 | -5.98% | 3 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $15.80 | +64.56% | 11 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $425 | $460.25 | -7.66% | 18 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $215 | $259.60 | -17.18% | 20 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $325 | $370.48 | -12.28% | 12 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 | $154.39 | n/a | 21 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $6 | $3.62 | n/a | 9 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $4.25 | $2.01 | n/a | 5 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $22.83 | n/a | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $15.71 | n/a | 9 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 → $36 | $29.04 | n/a | 2 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $32 | $5.66 | n/a | 1 | Nov 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 | $0.01 | n/a | 1 | Nov 30, 2018 |
Caris Life Sciences
Nov 6, 2026
Reiterated: Buy
Price Target: $28 → $36
Current: $23.04
Upside: +56.25%
10x Genomics
Nov 6, 2026
Reiterated: Hold
Price Target: $45 → $60
Current: $58.19
Upside: +3.11%
Bruker
Nov 5, 2026
Reiterated: Hold
Price Target: $53 → $64
Current: $61.59
Upside: +3.91%
Medline
Nov 5, 2026
Reiterated: Buy
Price Target: $55 → $47
Current: $39.47
Upside: +19.08%
Illumina
Nov 2, 2026
Reiterated: Sell
Price Target: $113 → $210
Current: $207.01
Upside: +1.44%
Thermo Fisher Scientific
Oct 23, 2026
Reiterated: Buy
Price Target: $685 → $800
Current: $700.22
Upside: +14.25%
Agilent Technologies
Aug 27, 2026
Reiterated: Buy
Price Target: $185 → $190
Current: $173.96
Upside: +9.22%
Fortrea Holdings
Jul 31, 2026
Reiterated: Buy
Price Target: $22
Current: $20.20
Upside: +8.91%
Danaher
Jul 22, 2026
Reiterated: Buy
Price Target: $230
Current: $233.02
Upside: -1.30%
Avantor
Jul 8, 2026
Reiterated: Hold
Price Target: $9 → $11
Current: $15.54
Upside: -29.21%
Jul 8, 2026
Reiterated: Buy
Price Target: $265
Current: $337.97
Upside: -21.59%
Jul 8, 2026
Reiterated: Buy
Price Target: $150 → $215
Current: $151.70
Upside: +41.73%
Jul 8, 2026
Reiterated: Buy
Price Target: $1,550
Current: $1,738.91
Upside: -10.86%
Jul 8, 2026
Reiterated: Hold
Price Target: $13 → $18
Current: $10.74
Upside: +67.60%
Jun 29, 2026
Downgraded: Hold
Price Target: $70 → $73
Current: $72.80
Upside: +0.27%
May 29, 2026
Reiterated: Hold
Price Target: $120 → $140
Current: $194.65
Upside: -28.08%
May 28, 2026
Reiterated: Buy
Price Target: $23
Current: $16.61
Upside: +38.47%
Apr 29, 2026
Reiterated: Hold
Price Target: $55 → $38
Current: $49.89
Upside: -23.83%
Apr 24, 2026
Reiterated: Buy
Price Target: $375 → $400
Current: $416.42
Upside: -3.94%
Apr 7, 2026
Downgraded: Hold
Price Target: $375 → $300
Current: $366.36
Upside: -18.11%
Apr 7, 2026
Rated: Hold
Price Target: $200
Current: $265.12
Upside: -24.56%
Apr 7, 2026
Reiterated: Buy
Price Target: $300
Current: $319.09
Upside: -5.98%
Apr 7, 2026
Reiterated: Buy
Price Target: $26
Current: $15.80
Upside: +64.56%
Apr 7, 2026
Rated: Buy
Price Target: $425
Current: $460.25
Upside: -7.66%
Feb 11, 2026
Reiterated: Hold
Price Target: $215
Current: $259.60
Upside: -17.18%
Jan 2, 2026
Reiterated: Buy
Price Target: $325
Current: $370.48
Upside: -12.28%
May 22, 2025
Reiterated: Buy
Price Target: $135
Current: $154.39
Upside: n/a
Feb 26, 2025
Reiterated: Buy
Price Target: $9 → $6
Current: $3.62
Upside: n/a
Mar 23, 2023
Reiterated: Hold
Price Target: $1.5 → $4.25
Current: $2.01
Upside: n/a
Mar 1, 2023
Reiterated: Buy
Price Target: $62
Current: $22.83
Upside: n/a
Feb 24, 2023
Reiterated: Buy
Price Target: $6
Current: $15.71
Upside: n/a
Aug 14, 2019
Reiterated: Hold
Price Target: $32 → $36
Current: $29.04
Upside: n/a
Nov 30, 2018
Upgraded: Hold
Price Target: $32
Current: $5.66
Upside: n/a
Nov 30, 2018
Reiterated: Hold
Price Target: $4.5
Current: $0.01
Upside: n/a